SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Vector1 who wrote (6088)12/7/1998 11:24:00 AM
From: RCMac  Read Replies (1) of 9719
 
V1 and Rman, Since you sold SEPR out of the portfolio on November 20 at 80 1/8,
(a) the stock has risen, to Friday's close of 88,
(b) SEPR and Lilly announced a Prozac deal this morning, and managed to get it on the front page of the WSJ [the deal is pretty favorable and was expected, cf. Message 6540521 ], and
(c) SEPR traded up to about 95 and has sold off to about 86, as the "sell on the news" traders bail out.

Is this a time for the portfolio to get back in to SEPR? It seems to me that the chance of getting SEPR at prices much lower than this are fairly slim, or do you still disagree on this?

-- RCM
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext